Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Estriol: Women's Choice vs. A Manufacturer's Greed

Author(s):  Goodrum Jennifer

Issue:  Jul/Aug 2008 - Hormone Replacement Therapy
View All Articles in Issue

Abstract:  The U.S. Food and Drug Administration recently took action to†hal4 the compounding of hormone preparations that contain estriol, an action requested in a citizen petition filed by Wyeth Pharmaceuticals. If the Food and Drug Administration, with the support of Wyeth, is successful in its efforts, women throughout the U.S. who rely on compounded hormones containing estriol will have to discontinue their prescribed treatment. The International Academy of Compounding Pharmacists is engaged in ongoing outreach to ensure that members of Congress recognize the importance of protecting pharmacy compounding for the health and well-being of their constituents. Significant progress has been made with the recent introduction of a congressional resolution in support of estriol.

Related Keywords: Jennifer Goodrum, estriol, U.S. Food and Drug Administration, FDA, regulation, Wyeth, bioidentical hormone replacement therapy, estrogen, BHRT


Printer-Friendly Version

Download in electronic PDF format for $55

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
The Science Behind Hormone Replacement Therapy, Part 1 Wepfer Scott T Nov/Dec 2001 462-464 Buy
Bioidentical Hormone Replacement Therapy, Part 3, A Review of Wepfer Scott T Mar/Apr 2002 142-146 Buy
Estriol: Women's Choice vs. A Manufacturer's Greed Goodrum Jennifer Jul/Aug 2008 286-292 Buy
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Gillson George R, Zava David T Jul/Aug 2003 250-256 Buy
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Deleruyelle Laura J Sep/Oct 2016 359-364 Buy
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J Jul/Aug 2004 313-319 Buy
Hormone Replacement Therapy: Part 1 - The Evolution of Hormone Treatment Lorentzen Jean Sep/Oct 2001 336-338 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line Snow Stephen T, Stannard Robert W, Bellis Jennifer, Moss Carrie A Jan/Feb 2019 32-33 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy